CXCR2 and neoplasm: This notion is supported by the evidence that, in a model of syngeneic renal cell carcinoma, CXCR2 ligand expression increased with tumor growth, whereas there was a significant inhibition in the CXCR2−/− mice that correlated with decreased angiogenesis and necrosis.